h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
SCVIi002-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
SCVIi002-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
SCVIi002-A (RRID:CVCL_A5FV)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
8th January 2021
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Stanford Cardiovascular Institute (SCVI)
External Databases
Cellosaurus
CVCL_A5FV
Wikidata
Q107116870
General Information
Publications
Liu L et al. Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy. Stem cell research. 2021 May;53:102279.
Mondéjar-Parreño G et al. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome. Stem cell research. 2021 Jul;54:102402.
Caudal A et al. Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients. Stem cell research. 2022 Aug;63:102855.
Zeng W et al. Generation of two induced pluripotent stem cell lines from spinal muscular atrophy type 1 patients carrying no functional copies of SMN1 gene. Stem cell research. 2023 Jun;69:103095.
Zhu W et al. Generation of two induced pluripotent stem cell lines from patients with Down syndrome. Stem cell research. 2023 Oct;72:103204.
Karakan MÇ et al. Geometry and length control of 3D engineered heart tissues using direct laser writing. Lab on a chip. 2024 Mar 12;24(6):1685-1701.
Kathirgamanathan Abiramee et al. Preventing Atrial Fibrillation in Hypertrophic Cardiomyopathy using Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs). Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. 2024-03-15.
Ribeiro M et al. Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation. Human cell. 2024 Jul;37(4):1205-1214.
Jager Joanna et al. Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic Cardiomyopathy. Stem Cell Research. 2024-12-00.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.